Aktis Oncology, Inc. (AKTS) — Institutional Holders, Q2 2026 (page 2)
114 institutional investment managers reported a AKTS position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.1B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 114. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
AKTS 13F holders ranked 101–114 of 114
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 101 | ROTHSCHILD INVESTMENT#101 · 39 sh | 39 | $1.3K | 0.00% | New |
| 102 | Quarry#102 · 34 sh | 34 | $1.1K | <0.01% | New |
| 103 | SJS Investment Consulting#103 · 33 sh | 33 | $1.1K | — | New |
| 104 | Covestor Ltd#104 · 23 sh | 23 | $1.0K | <0.01% | New |
| 105 | CoreCap Advisors#105 · 29 sh | 29 | $935.00 | — | New |
| 106 | WPG Advisers#106 · 25 sh | 25 | $806.00 | <0.01% | New |
| 107 | FWL INVESTMENT MANAGEMENT#107 · 23 sh | 23 | $741.00 | <0.01% | New |
| 108 | GAMMA Investing#108 · 20 sh | 20 | $645.00 | — | New |
| 109 | Rossby Financial, LCC#109 · 18 sh | 18 | $580.00 | <0.01% | New |
| 110 | Caitong International Asset Management , Ltd#110 · 8 sh | 8 | $258.00 | 0.00% | New |
| 111 | Clearstead Advisors#111 · 6 sh | 6 | $195.00 | 0.00% | New |
| 112 | Essential Partners#112 · 4 sh | 4 | $129.00 | — | New |
| 113 | Freestone Grove Partners#113 · 2 sh | 2 | $64.00 | 0.00% | New |
| 114 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#114 · 288 sh | 288 | — | — | New |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.